Quebec-based COVID-19 vaccine maker Medicago to shut down
A year ago, Medicago's plant-based COVID-19 vaccine, Covifenz, was approved by Health Canada and touted as a homegrown weapon in the fight against SARS-CoV-2. Medicago owner Mitsubishi Chemical Group said on Thursday that it was terminating "all its activities with Medicago," citing "significant changes" to the vaccine market.
